Method of inhibiting the proliferation of B cell cancers...

Details Method of inhibiting the proliferation of B cell cancers... Method of inhibiting the proliferation of B cell cancers...

2011-01-04

2011-01-04

Blanchard, David J. (Department: 1643)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

C424S158100, C435S069600, C435S069700, C435S320100, C435S326000, C530S387300, C530S388230

Reexamination Certificate

active

07862814

ABSTRACT:
Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.

REFERENCES:
patent: 5523227 (1996-06-01), Bram et al.
patent: 5541291 (1996-07-01), Keene
patent: 5650550 (1997-07-01), Korach et al.
patent: 5739277 (1998-04-01), Presta et al.
patent: 5969102 (1999-10-01), Bram et al.
patent: 6316222 (2001-11-01), Bram et al.
patent: 6500428 (2002-12-01), Bram et al.
patent: 6774106 (2004-08-01), Theill et al.
patent: 7501497 (2009-03-01), Rixon et al.
patent: 2003/0103986 (2003-06-01), Rixon et al.
patent: 2005/0183148 (2005-08-01), Bram et al.
patent: 2006/0067933 (2006-03-01), Gross et al.
patent: 2007/0264689 (2007-11-01), Gross et al.
patent: 2009/0209006 (2009-08-01), Rixon et al.
patent: 0869180 (1998-10-01), None
patent: WO 94/09137 (1994-04-01), None
patent: WO 95/35501 (1995-12-01), None
patent: WO 96/18641 (1996-06-01), None
patent: WO 96/27011 (1996-09-01), None
patent: WO 97/09137 (1997-03-01), None
patent: WO 97/33902 (1997-09-01), None
patent: WO 98/18921 (1998-05-01), None
patent: WO 98/27114 (1998-06-01), None
patent: WO 98/39361 (1998-09-01), None
patent: WO 98/55620 (1998-12-01), None
patent: WO 98/55621 (1998-12-01), None
patent: WO 99/04001 (1999-01-01), None
patent: WO 99/11791 (1999-03-01), None
patent: WO 99/12965 (1999-03-01), None
patent: WO 00/40716 (2000-07-01), None
patent: WO 00/43032 (2000-07-01), None
patent: WO 00/62790 (2000-10-01), None
patent: WO 00/67034 (2000-11-01), None
patent: WO 01/12812 (2001-02-01), None
patent: WO 01/24811 (2001-04-01), None
patent: WO 01/60397 (2001-08-01), None
patent: WO 01/77342 (2001-10-01), None
patent: WO 01/81417 (2001-11-01), None
patent: WO 01/87977 (2001-11-01), None
patent: WO 02/14504 (2002-02-01), None
patent: WO 02/38766 (2002-05-01), None
U.S. Appl. No. 60/199,946, filed Apr. 27, 2000, Ambrose et al.
U.S. Appl. No. 09/569,245, filed May 11, 2000, Gross et al.
U.S. Appl. No. 09/627,206, filed Jul. 27, 2000, Gross et al.
Gross et al.,Immunity, 15(2) :289-302, Aug. 2001.
Gross et al.,Nature, 404 :995-999, Apr. 27, 2000.
Bairoch, A.,Nucl. Acid Res. 21(13):3097-3103, 1993.
Bram, R. J. and Crabtree, G. R.,Nature371:355-358, 1994.
Bram, R. J. et al.,Mol. Cell. Biol. 13(8):4760-4769, 1993.
Clipstone, N. A. and Crabtree, G. R.,Nature 357:695-697, 1992.
Crabtree, G. R. and Clipstone, N. A.,Annu. Rev. Biochem. 63:1045-1083, 1994.
Cyster, J. G.,Nature Immunology 1(1):9-10, 2000.
Emmel, E. A., et al.,Science 246:1617-1620, 1989.
Fiering, S. et al.,Genes Dev. 4:1823-1834, 1990.
Friedman, J. Weissman, I,Cell66:799-806, 1991.
Gao, X. et al.,Neurochemical Research24(9):1181-1188, 1999.
Gras, et al.,International Immumol, 7(7):1093-1106, 1995.
Holloway, M. P., and Bram, R. J.,J. Biol. Chem. 273:16346-16350, 1998.
Holloway, M. P., and Bram, R. J.,J. Biol. Chem. 271:8549-8552, 1996.
Hoth, M. and Prenner, R.J., Physiol., 465:359-386, 1993.
Yu et al.,Nature Immunology 1(3):252-256, 2000.
Hatzoglou, A et al.,The Journal of Immunology 165:1322-1330, 2000.
Imboden, J. B. et al.,Immunol, 134:663-665, 1985.
Karttunen, J. and Shastri, N.,Proc. Natl. Acad. Sci. USA88:3972-3976, 1991.
Khare, S. D., et al.,Proc. Natl. Acad. Sci., USA97(7):3370-3375, Mar. 28, 2000.
Laâbi, et al.,EMBO J. 11:3897-3904, 1992.
Laâbi, et al.,Nucleic Acids Res. 22:1147-1154, 1994.
Liu, J. et al.,Cell66:807-815, 1991.
Mackay, et al.,J. Exp. Med. 190:1697-1710, 1999.
Madry, et al.,Immunol. 10:1693-1702, 1998.
Marsters, S. A., et al.,Current Biology10:785-788, 2000.
Moore, et al.,Science285:260-263, 1999.
Mukhopadhyay, et al.,J. Biol. Chem. 274(23):15978-15981, 1999.
Novak, Anne J. et al.,Blood103(2):689-694, 2004.
O'Keefe, S. J. et al.,Nature357:692-694, 1992.
Premack, B. A. et al.,Immunol. 152:5226-5240, 1994.
Putney, J. W., Jr. and Bird, G. St. J.,Cell75:199-201, 1993.
Rudinger, J.,Peptide Hormones: 1-7, 1976.
Schneider, et al.,J. Exp. Med., 189(11):1747-1756, 1999.
Shu, et al.,J. Leukocyte Biol., 65:680-683, May 1999.
Stryer, Lubert, “Flow of Genetic Information,”Biochemistry:111, 1996.
Takebe, Y., et al.,Mol. Cell, Biol. 8:466-472, 1988.
Tashiro, K., et al.,Science261:600-603, 1993.
Thompson, J. S., et al.,Journal of Experimental Medicine192(1):129-135, 2000.
Truneth, A., et al.,Nature313:318-321, 1985.
Verweij, C. L. et al.,J. Biol. Chem. 265:15788-15795, 1990.
Von Bülow, Götz-Ulrich and Bram, Richard,Science278:138-141, 1997.
Von Bülow, Götz-Ulrich et al.,Blood90(10):246A-247, 1997.
Ware, C. F.,Nature404:949-950, 2000.
Weiss, A. and Littman, D. R.,Cell76:263-274, 1994.
Xia, X. et al.,Journal of Experimental Medicine192(1):137-143, 2000.
Yan, M. et al.,Nature Immunology 1(1):37-41, 2000.
Zweifach, A. and Lewis, R. S.,Proc. Natl. Acad. Sci. USA90:6295-6299, 1993.
Birren et al.,EMBL Accession No. AC003958, Jan. 6, 1998.
Hillier et al.,GenBank Accession No. H47097, Aug. 16, 1995.
Hillier et al.,GenBank Accession No. R24371, 1995.
Mishra,GenBank Accession No. V64412, Mar. 1, 1999.
Ramser, et al.,GenBank Accession No. AL353996, May 20, 2000.
Von Bülow et al.,Mammalian Genome 11: 628-632, 2000.
Wells et al.,Nature Biotech. 17:25-26, 1999.
Zhou et al.,Blood 98(11):808a, Abstract 3361, 2001.
Kolb, et al.,Gene 227:21-31, 1999.
Sigmund C.,Arterioscler. Thromb. Vasc. Biol. 1425-1429, 2000.

Affiliated with

Also associated with

Rating

Method of inhibiting the proliferation of B cell cancers... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting the proliferation of B cell cancers..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting the proliferation of B cell cancers... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2723804